These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37371795)
21. Does allergen immunotherapy for allergic rhinitis prevent asthma? Arshad SH Ann Allergy Asthma Immunol; 2022 Sep; 129(3):286-291. PubMed ID: 35500864 [TBL] [Abstract][Full Text] [Related]
22. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4. Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673 [TBL] [Abstract][Full Text] [Related]
23. House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis. Feng M; Zeng X; Li J J Thorac Dis; 2019 Aug; 11(8):3616-3625. PubMed ID: 31559069 [TBL] [Abstract][Full Text] [Related]
24. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis. Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092 [TBL] [Abstract][Full Text] [Related]
25. Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy. Justicia JL; Padró C; Roger A; Moreno F; Rial MJ; Parra A; Valero A; Malet A; Teniente A; Boronat A; Torán-Barona C World Allergy Organ J; 2021 Jun; 14(6):100545. PubMed ID: 34178239 [TBL] [Abstract][Full Text] [Related]
26. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915 [TBL] [Abstract][Full Text] [Related]
27. Real-World Safety and Effectiveness Evidence of a Microcrystalline Tyrosine-Associated Mite Allergoid in Children and Adolescents with Allergic Rhinitis. Anna SC; Zulay M AS; Ignacio GN; Sofia L; Juan A MT; Maria D M; Ramón N; Mercedes R; Anna B; Carla TB; José L J Allergol Immunopathol (Madr); 2021; 49(4):98-108. PubMed ID: 34224224 [TBL] [Abstract][Full Text] [Related]
28. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
29. Early Intervention Improves Clinical Responses to House Dust Mite Immunotherapy in Allergic Rhinitis Patients. Qi S; Chen H; Huang N; Li W; Liu G; Wang Y; Hu L; Wang X; Zhang W; Zhu R Int Arch Allergy Immunol; 2016; 171(3-4):234-240. PubMed ID: 28049194 [TBL] [Abstract][Full Text] [Related]
30. Salivary IgG4 Levels Contribute to Assessing the Efficacy of Liu J; Hu M; Tao X; He J; Wang J; Song Z; Wu L; Tang L; Chen Z; Xu X J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836200 [TBL] [Abstract][Full Text] [Related]
31. High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study. Fritszching B; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Contoli M Front Pediatr; 2023; 11():1136942. PubMed ID: 37063677 [TBL] [Abstract][Full Text] [Related]
36. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial. Bożek A; Kołodziejczyk K; Kozłowska R; Canonica GW Clin Transl Allergy; 2017; 7():43. PubMed ID: 29214012 [TBL] [Abstract][Full Text] [Related]
37. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy. Liu Y; Xing Z; Wang J; Geng C Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065 [TBL] [Abstract][Full Text] [Related]
38. MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis. Ferrando M; Bagnasco D; Passalacqua G; Varricchi G; Canonica GW Expert Opin Biol Ther; 2016 Nov; 16(11):1435-1441. PubMed ID: 27620194 [TBL] [Abstract][Full Text] [Related]
39. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan. Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930 [TBL] [Abstract][Full Text] [Related]
40. Improved pulmonary function test (PFT) after 1 one year of Sublingual Immunotherapy (SLIT) in unison with pharmacotherapy in mild allergic asthmatics. Beigh AH; Rasool R; Kawoosa F; Manzoor S; Rashid R; Andrabi KI; Shah ZA; Qureshi T Immunol Lett; 2021 Feb; 230():36-41. PubMed ID: 33340589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]